Clinical Trial Update: Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers

View source ↗

Summary

A prospective surveillance study on Respiratory Syncytial Virus infections in infants and toddlers has completed, sponsored by Sanofi Pasteur.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Respiratory Syncytial Virus Infections | Status: COMPLETED